Search papers, labs, and topics across Lattice.
This study introduces ClinRAG-GRAPH, a novel framework for predicting pre-treatment pathological complete response (pCR) in breast cancer patients undergoing neoadjuvant chemotherapy, addressing challenges such as cross-modal modeling and imaging heterogeneity. By leveraging a dual-branch domain-adversarial learning strategy, the model effectively mitigates MRI protocol biases while enhancing the interpretability of predictions through a large language model-driven retrieval mechanism. The results indicate strong performance, achieving AUCs of 0.815 on the internal test set and 0.774/0.712 on two external test sets, underscoring its robustness across diverse clinical settings.
ClinRAG-GRAPH achieves impressive pCR prediction accuracy while ensuring interpretability and robustness against imaging biases across multiple centers.
Neoadjuvant chemotherapy (NAC) response prediction is clinically important for treatment stratification in breast cancer. However, robust pre-treatment pathological complete response (pCR) prediction remains challenging due to insufficient cross-modal modeling, multicenter imaging heterogeneity, and weak evidence-grounded interpretability. We propose ClinRAG-GRAPH, a Clinically informed Retrieval-Augmented Generation Graph framework, for pre-treatment pCR prediction from DCE-MRI, structured clinical variables, and biopsy-derived pathological biomarkers. ClinRAG-GRAPH constructs an intra-patient clinical-prior graph and applies a prior-guided relation-aware graph convolutional network for structured multimodal representation learning. To improve cross-center robustness, we introduce a dual-branch domain-adversarial learning strategy to suppress protocol-related MRI bias while preserving pCR-relevant features. To enhance interpretability, we further incorporate large language model (LLM)-driven subgraph RAG module that retrieves clinically analogous historical cases and integrates retrieved evidence for pCR inference. We assemble a large-scale multicenter NAC breast cancer cohort for extensive validation, drawing from two public sources and three in-house centers.Results show that ClinRAG-GRAPH achieves AUCs of 0.815 on the internal test set and 0.774/0.712 on two external test sets, demonstrating robust pre-treatment pCR prediction across centers. The code is available at the anonymized https://github.com/miccai26-1181/ClinRAG-GRAPH.
